Cue Biopharma, Inc. (CUE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cue Biopharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.09x | -1.51x | -2.38x | -1.92x | -8.01x | -8.01x |
| P/B Ratio | 1.09x | 3.51x | 3.26x | 1.55x | 5.40x | 4.55x |
| P/S Ratio | 1.05x | 6.61x | 22.00x | 81.61x | 23.68x | 113.78x |
| Profitability | ||||||
| Gross Margin | 87.3% | 100.0% | -593.9% | 100.0% | 111.9% | -963.5% |
| Operating Margin | -96.7% | -446.9% | -949.9% | -4275.1% | -292.6% | -1428.0% |
| Net Margin | -96.9% | -438.0% | -924.1% | -4257.8% | -295.6% | -1419.8% |
| EBITDA Margin | -83.9% | -404.1% | -838.8% | -4055.5% | -304.1% | -1394.4% |
| Liquidity | ||||||
| Current Ratio | 2.74x | 1.84x | 3.01x | 6.68x | 5.35x | 5.36x |
| Quick Ratio | 2.74x | 1.84x | 3.01x | 6.68x | 5.35x | 5.36x |
| Leverage | ||||||
| Debt/Equity | 0.16x | 0.51x | 0.40x | 0.29x | 0.18x | 0.09x |
YoY = year-over-year change. Source: FMP..